ASX:LTPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
LTR Pharma Ltd
$0.475
+$0.020 (+4.40%)
Day Range
$0.460 – $0.475
52 Week Range
$0.323 – $0.810
Volume
134.13K
Avg Volume (10D)
158.80K
Market Cap
$86.34M
Price Chart
Market Statistics
Open$0.465
Previous Close$0.455
Day High$0.475
Day Low$0.460
52 Week High$0.810
52 Week Low$0.323
Valuation
Market Cap86.34M
Shares Outstanding181.78M
Price to Book3.08
Trading Activity
Volume134.13K
Value Traded62.46K
Bid$0.460 × 37,100
Ask$0.475 × 1,199
Performance
1 Day-6.19%
5 Day1.11%
13 Week8.33%
52 Week31.88%
YTD-36.81%
Technical Indicators
RSI (14)47.47
50-Day SMA$0.499
200-Day SMA$0.484
Latest News
Biotechnology
LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
Hot Topics
The Weekly Finger: On Green and Gold, and Oil and Gold
Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.
Biotechnology
LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS
LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.
Biotechnology
LTR Pharma Unveils Strong SPONTAN Data and Dual US Strategy
LTR Pharma reports SPONTAN PK: 5 mg intranasal Tmax 10 min vs 60 min oral; FDA 505(b)(2) pathway; dual US strategy; $24.1m cash, 2026 milestones